These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6971883)

  • 21. Inhibition in corticotrophin and corticosterone secretion following photic stimulation in rats with 6-hydroxydopamine injection into the medial forebrain bundle.
    Feldman S; Melamed E; Conforti N; Weidenfeld J
    J Neurosci Res; 1984; 12(1):87-92. PubMed ID: 6090684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of neurotoxin-induced brainstem lesions on the respiratory responses of conscious rats.
    Martin-Body RL; Grundy HR
    Clin Exp Pharmacol Physiol; 1985; 12(4):427-37. PubMed ID: 3937648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Locomotor activity and ingestive behavior after damage to ascending serotonergic systems.
    Heym J; Gladfelter WE
    Physiol Behav; 1982 Sep; 29(3):459-67. PubMed ID: 7178251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurogenic hypertension after depletion of norepinephrine in anterior hypothalamus induced by 6-hydroxydopamine administration into the ventral pons: role of serotonin.
    Benarroch EE; Balda MS; Finkielman S; Nahmod VE
    Neuropharmacology; 1983 Jan; 22(1):29-34. PubMed ID: 6405300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intra-raphe neurokinin-induced hyperactivity: effects of 5,7-dihydroxytryptamine lesions.
    Paris JM; Mitsushio H; Lorens SA
    Brain Res; 1989 Jan; 476(1):183-8. PubMed ID: 2464417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral effects of neurotoxic lesions of the ascending monoamine pathways in the rat brain.
    Heybach JP; Coover GD; Lints CE
    J Comp Physiol Psychol; 1978 Feb; 92(1):58-70. PubMed ID: 627639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective neurotoxic lesions of descending serotonergic and noradrenergic pathways in the rat.
    Berge OG; Fasmer OB; Tveiten L; Hole K
    J Neurochem; 1985 Apr; 44(4):1156-61. PubMed ID: 3919157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine.
    Erinoff L; Snodgrass SR
    Pharmacol Biochem Behav; 1986 Apr; 24(4):1039-45. PubMed ID: 3086901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal intraspinal 6-hydroxydopamine, 5,7-dihydroxytryptamine or their combination: effects on nociception and morphine analgesia.
    Pappas B; Ings R; Roberts D
    Eur J Pharmacol; 1982 Dec; 86(2):157-66. PubMed ID: 6819155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noradrenergic mediation of adrenocortical responses following cortical stimulation in the rat.
    Feldman S; Conforti N; Melamed E
    Isr J Med Sci; 1986; 22(7-8):591-3. PubMed ID: 3096910
    [No Abstract]   [Full Text] [Related]  

  • 31. Are ascending noradrenergic and serotonergic pathways necessary for effects of electroconvulsive treatment? Clonidine hypothermia and forced swim study.
    Danysz W; Kostowski W; Hauptmann M; Bidzinski A
    Pol J Pharmacol Pharm; 1989; 41(1):15-22. PubMed ID: 2511561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction in excessive muscle tone by selective depletion of serotonin in intercollicularly decerebrated rats.
    Sakai M; Matsunaga M; Kubota A; Yamanishi Y; Nishizawa Y
    Brain Res; 2000 Mar; 860(1-2):104-11. PubMed ID: 10727628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficits in inhibitory avoidance after neurotoxic lesions of the ventral striatum are neurochemically and behaviorally selective.
    Schwarting R; Carey RJ
    Behav Brain Res; 1985 Dec; 18(3):279-83. PubMed ID: 2868738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral correlates of serotonin depletion.
    Harvey JA; Schlosberg AJ; Yunger LM
    Fed Proc; 1975 Aug; 34(9):1796-801. PubMed ID: 125207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevations in nociceptive thresholds following locus coeruleus lesions.
    Bodnar RJ; Ackermann RF; Kelly DD; Glusman M
    Brain Res Bull; 1978; 3(2):125-30. PubMed ID: 647413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noradrenergic-serotonergic interactions and nociception in the rat.
    Archer T; Jonsson G; Minor BG; Post C
    Eur J Pharmacol; 1986 Jan; 120(3):295-307. PubMed ID: 3081358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methyldopa hypotension and ascending projections from midline serotonin (B3) cells in the medulla.
    Chalmers JP; Macrae M; Minson JB; Kapoor V
    J Hypertens Suppl; 1985 Dec; 3(3):S111-2. PubMed ID: 2856683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of modification of brain serotonin (5-HT), norepinephrine (NE) and dopamine (DA) on ethanol tolerance.
    Lê AD; Khanna JM; Kalant H; LeBlanc AE
    Psychopharmacology (Berl); 1981; 75(3):231-5. PubMed ID: 6798612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central noradrenergic neurons: differential effects on body weight of electrolytic and 6-hydroxydopamine lesions in rats.
    Lorden J; Oltmans GA; Margules DL
    J Comp Physiol Psychol; 1976 Feb; 90(2):144-55. PubMed ID: 1249269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tail temperature in rats after intraventricular injections of 6-hydroxydopamine or 5,7-dihydroxytryptamine.
    Ishikawa Y; Matuszek M; Nakayama T
    Neurosci Lett; 1980 Nov; 20(2):177-81. PubMed ID: 7443067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.